Table 3.
Adults age | participants | IP | IPP | IPP-ratio | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
a | 95% | CI | ninj | 95% | CI | ninj /a | 95% | CI | IPP/IPP | 95% | CI | |
16–19 | 197 | 170 | 224 | 76 | 63 | 89 | 0,39 | 0,32 | 0,45 | 1 | ||
20–29 | 467 | 428 | 506 | 138 | 119 | 157 | 0,30 | 0,25 | 0,34 | 0,76 | 0,60 | 0,95 |
30–39 | 410 | 373 | 447 | 114 | 96 | 132 | 0,28 | 0,23 | 0,32 | 0,71 | 0,58 | 0,88 |
40–49 | 494 | 454 | 534 | 124 | 105 | 143 | 0,25 | 0,21 | 0,29 | 0,64 | 0,52 | 0,80 |
50–59 | 465 | 426 | 504 | 97 | 80 | 114 | 0,21 | 0,17 | 0,25 | 0,53 | 0,42 | 0,68 |
60–69 | 425 | 388 | 462 | 49 | 36 | 62 | 0,12 | 0,08 | 0,15 | 0,30 | 0,22 | 0,41 |
70+ | 426 | 389 | 463 | 23 | 14 | 32 | 0,05 | 0,03 | 0,08 | 0,14 | 0,09 | 0,22 |
Participation, “a” number of participants
IP injury prevalence, “ninj” number of injuries
IPP injury prevalence proportion in different activities of adults, ninj/a the proportion
IPP-ratio prevalence proportion-ratio, IPP/IPP the ratio between injury proportions
CI confidence interval